Filter Results:
- Full text PDF available (1)
Publication Year
1995
2005
- This year (0)
- Last 5 years (0)
- Last 10 years (0)
Publication Type
Co-author
Journals and Conferences
Learn More
- Ian Stewart Fraser, Pekka Lähteenmäki, +8 authors Harold A. Nash
- Human reproduction
- 1999
A total of 107 sexually active women, aged 18-35 years, was recruited through family planning clinics in four centres in different countries. Each woman underwent two or three gentle but thorough and… (More)
- Kaisa Elomaa, Rune Rolland, +4 authors Pekka Lähteenmäki
- American journal of obstetrics and gynecology
- 1998
OBJECTIVE
Our purpose was to test the hypothesis that omitting the first three pills of the contraceptive cycle leads to ovulation.
STUDY DESIGN
Ninety-nine women, randomly assigned to 1 of 3… (More)
- Kaisa Elomaa, Pekka Lähteenmäki
- Contraception
- 1999
The ovulatory potential of preovulatory follicles was studied in five women taking monophasic gestodene pills containing 20 micrograms of ethinyl estradiol. After one normal pill cycle, follicles… (More)
- Vivian Brache, Daniel R. Mishell, +4 authors Aníbal Faundes
- Contraception
- 2001
Contraceptive vaginal rings delivering various progestins alone or in combination with estrogen have been previously studied, showing adequate steroid vaginal absorption and acceptability by the… (More)
- Irving Sivin, Daniel R. Mishell, +10 authors Theodore M. Jackanicz
- Contraception
- 2005
In a multicenter 1-year trial of contraceptive vaginal rings (rings) involving 150 women, three dose combinations of the progestin Nestorone (NES) and ethinylestradiol (EE) were compared with respect… (More)
- István Batár, Aki Kuukankorpi, Mika Siljander, Kaisa Elomaa, Ilkka Rauramo
- Contraception
- 2002
In an open, single-group, phase III clinical trial of 5 years, the clinical performance of NOVA T 380 was investigated in three centers. The device having a higher copper surface of 380 mm(2) is a… (More)
- Päivi I Pakarinen, Tapani Luukkainen, +4 authors Pekka Lähteenmäki
- Contraception
- 1996
A randomized study was performed in two clinics in order to compare the efficacy, safety and acceptability of a new model of a levonorgestrel-releasing intracervical device situated either in the… (More)
- Kaisa Elomaa, Sirpa Ranta, Juhani Tuominen, Pekka Lähteenmäki
- Human reproduction
- 2001
Ovulatory potential was studied during the use of two oral contraceptive pill preparations, after repeated mid-cycle administration of activated charcoal. Eleven women used monophasic pills… (More)
- Janne V J Suvisaari, Alfred J. Moo-Young, Auni Juhakoski, Kaisa Elomaa, Samir I. Saleh, Pekka Lähteenmäki
- Contraception
- 1999
We studied the pharmacokinetics of 7 alpha-methyl-19-nortestosterone (MENT), a potent synthetic androgen, administered by subdermal implants. The implants contained 112 +/- 4 mg of MENT acetate in a… (More)
- P L Lähteenmäki, Caroline Bardin, +5 authors Juhani Tuominen
- Acta obstetricia et gynecologica Scandinavica…
- 1997
BACKGROUND
The levonorgestrel-releasing intrauterine system (LNg IUS) is a hormonal contraceptive that is used in the uterine cavity. To determine whether the reasons for choosing LNg IUS vs.… (More)